Endothelins are potent peptide mediators that elicit glycogenolytic an
d vasoconstrictor actions in the liver. Endothelins were found to stim
ulate the synthesis and release of the lipid mediator platelet-activat
ing factor in cultured rat Kupffer cells. Endothelin-mediated synthesi
s of platelet-activating factor required extracellular calcium in that
the calcium chelator, EGTA and nifedipine, a calcium ion channel bloc
ker, inhibited platelet-activating factor synthesis. The phospholipase
A(2) inhibitor 4-bromophenacyl bromide, strongly inhibited endothelin
-induced platelet activating factor synthesis, Endothelin-stimulated p
latelet activating factor synthesis was inhibited after treatment of K
upffer cells with cholera toxin, whereas pertussis toxin inhibited onl
y this response to endothelin-1. Agents that elevate intracellular cyc
lic AMP levels were found to inhibit endothelin-induced platelet-activ
ating factor synthesis in Kupffer cells. Staurosporine, a protein kina
se C inhibitor minimized endothelin-induced platelet-activating factor
synthesis but phorbol myristate acetate, an activator of protein kina
se C, did not affect endothelin-induced platelet activating factor syn
thesis. Thus, the current study demonstrates that activation of an end
othelin receptor in cultured rat Kupffer cells results in the synthesi
s and release of platelet-activating factor. The importance of endothe
lin-mediated platelet-activating factor synthesis relates to the mecha
nism of intercellular signaling occurring between endothelial cells (i
.e., the site of endothelin synthesis) and Kupffer cells (i.e., the si
te of formation of secondary mediators such as platelet-activating fac
tor and eicosanoids) within the rat liver exposed to various types of
pathophysiological episodes.